Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics

Thus, this innovative approach is better suited to rationally engineer and mass produce influenza CVV within significantly shorter timelines to enable an effective global response in pandemic situations.